← Back to patent-cliff list
CAS 116627-72-6
(E)-5-(2,6,6-trimethylcyclohex-1-en-1-yl)pent-4-en-2-ynenitrile
Codes: ALIT-016
Application context (from source-drug indications)
Kaposi's sarcomaAlitretinoinHIV infectionAlitretinoinPsoriasisAlitretinoinEczemaAlitretinoin口腔扁平苔藓AlitretinoinBreast cancerAlitretinoin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Alitretinoin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienal→(2E,4E,6Z,8E)-ethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate→(E)-2-(but-1-en-3-yn-1-yl)-1,3,3-trimethylcyclohex-1-ene→(E)-5-(2,6,6-trimethylcyclohex-1-en-1-yl)pent-4-en-2-ynenitrile→(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohex-1-en-1-yl)penta-2,4-dienenitrile→ethyl (E)-4-(diethoxyphosphoryl)-3-methylbut-2-enoate→ethyl (E)-4-(diethoxyphosphoryl)-3-methylbut-2-enoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.